Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ligand Pharmaceuticals has entered into an agreement with venBio Partners which permits venBio’s portfolio companies to enter into a pre-agreed worldwide OmniAb platform license agreement.
read more
Monday, November 26, 2018
Ligand has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located in Tempe, AZ.
read more
Ligand Pharmaceuticals Incorporated has announcedthe signing of a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion Pharmaceuticals, Inc., a venture-funded biotechnology company focused on ...
read more
Ligand announces the acquisition of economic rights to SB206 from Novan.
read more
Ligand Pharmaceuticals has announced the signing of an agreement with Ab Initio Biotherapeutics whereby Ligand will acquire Ab Initio for $12 million in cash.
read more
Thursday, August 04, 2022
LifeNet Health LifeSciences, a leader in all-human biomedical research solutions, is launching a new Cell-Based Assay Service following the acquisition of biotechnology firm IONTOX.
read more
Friday, September 08, 2017
Lifeline Pharmaceuticals announced improvements to its product line and logistics services through increased capabilities in its Mississippi Distribution Center.
read more
Wednesday, April 12, 2017
LifeCodexx AG, a European NIPT provider, and the Department of Obstetrics of the Charité have formed a research alliance to intensify research and development of a novel molecular genetic-based assay for the early detection of preeclampsia, a severe ...
read more
Life Technologies Corporation today announces plans to invest $18 million in a multi-phase plan to expand its facility in Pleasanton, Calif., where it will implement Current Good Manufacturing Practice (cGMP) capabilities for its genetic analysis ...
read more
Life Technologies (NASDAQ: LIFE) announced a major expansion of the existing manufacturing facilities at its European, Middle East and Africa headquarters at Inchinnan near Glasgow.
read more
Wednesday, March 27, 2013
Life Technologies Corporation today announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China's State Food and Drug Administration (SFDA) for clinical diagnostic use in China and the launch of 10 Assays from its ...
read more
Thursday, September 30, 2021
Responding to booming demand for FDA-regulated, temperature-controlled storage and distribution of pharmaceutical and medical devices, Dallas-based Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today...
read more
Building on its expertise in reagent and dye production, LI-COR is expanding its services to include synthesis and conjugation services for early-phase cGMP production.
read more
Wednesday, March 13, 2024
LGM Pharma, a provider of API and CDMO services for the full drug product lifecycle, announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing ...
read more
LGM Pharma announced new Analytical Services that provide analytical testing and stability services to pharmaceutical developers and manufacturers, including compounding pharmacies. The company is offering its analytical services expertise and ...
read more